30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Funding

Orthopedic Funding Covers Breadth of Industry in 1H19

Funding activity in 1H19 spanned all market segments of the orthopedic industry fairly evenly. We tracked 19 announcements, with spine representing five of those; joint replacement, trauma, sports medicine and orthobiologics each representing three and digital health/robotics representing two. We’ve found that much of the funding surrounds new technology. The list herein recaps 1H19 funding announcements and notes the amount of capital, when available, its intended use and the investor.

Investors Prioritize Care Delivery, Post-Revenue Companies

Extremities, sports medicine, digital health and the hospital supply chain remain attractive areas for orthopaedic innovation, according to investors who spoke during this year's Musculoskeletal New Ventures Conference. This seems like a natural course, with extremities and sports medicine being high-growth segments of orthopaedics and innovations in digital health and supply chain routinely mentioned as solutions to complex industry challenges. The sentiment that we took away from the discussion was optimism about the number of investment opportunities available, and about orthopaedics as a whole.

1H18 Funding Recap: Where'd They All Go?

Of the 10 companies that announced funding in the first half of the year, just four focus on traditional hardware. Others include biologics, artificial ligaments and software to support device customization.

1H17 Funding Recap: Investors Continue to Back Regulatory-Approved Orthopaedic Technologies

Funding announcements in 1H17 kept pace with the number of announcements made in the first halves of 2016 and 2015, signaling that the environment to raise capital remains consistent, but difficult. 

1H16 Funding Recap: Spine Remains Dominant Market for Investments

ORTHOWORLD reported 18 funding announcements in 1H16, compared to 23 in 1H15. Similar to recent years, the spine market was the largest target for funding.

Page Navigation
First